Fujirebio US Revenue and Competitors
Estimated Revenue & Valuation
- Fujirebio US's estimated annual revenue is currently $93.6M per year.
- Fujirebio US's estimated revenue per employee is $251,000
Employee Data
- Fujirebio US has 373 Employees.
- Fujirebio US grew their employee count by 6% last year.
Fujirebio US's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Director, Manufacturing Operations | Reveal Email/Phone |
3 | Director Finance and Accounting | Reveal Email/Phone |
4 | Sr. Director, Clinical and Regulatory Science | Reveal Email/Phone |
5 | Director Quality Assurance | Reveal Email/Phone |
6 | Director, Materials Management | Reveal Email/Phone |
7 | Director, Global OEM Business Planning | Reveal Email/Phone |
8 | Director Technical Manufacturing | Reveal Email/Phone |
9 | Director Engineering | Reveal Email/Phone |
10 | Sr. Clinical Market Development Manager | Reveal Email/Phone |
Fujirebio US Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 293 | 12% | N/A | N/A |
#2 | $7M | 28 | -10% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 37 | -10% | N/A | N/A |
#6 | $56.2M | 179 | 0% | N/A | N/A |
#7 | $38.9M | 155 | -1% | N/A | N/A |
#8 | $22.1M | 88 | 5% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is Fujirebio US?
Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD). It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, Fujirebio’s global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network. Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Its IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Fujirebio is today a member of Miraca Group (Miraca Holdings Inc. listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1.200 people in Asia, Europe and America.
keywords:N/AN/A
Total Funding
373
Number of Employees
$93.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fujirebio US News
New Jersey, United States The study is a professional and comprehensive ... Abbott Laboratories, Ortho Clinical Diagnostics, Fujirebio (Miraca Group),...
California (United States) The Tropical Spastic Paraparesis Diagnosis Market ... MP Biomedicals, Fujirebio, Inc., Quest Diagnostics,...
New Jersey, United States The Cytology and HPV Testing Market ... Abbott, Arbor Vita, Becton Dickinson, Cepheid, Roche, Fujirebio,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $123.4M | 395 | N/A | N/A |
#2 | $146.8M | 405 | 7% | N/A |
#3 | $83.3M | 409 | 30% | N/A |
#4 | $15M | 412 | 17% | N/A |
#5 | $163.5M | 451 | 5% | N/A |